[Vaccines against coronavirus disease 2019 (COVID-19) : Efficacy comparison, safety aspects, and current challenges][2019 코로나바이러스 감염증(COVID-19) 예방백신 : 효능비교, 안전성 측면 및 당면과제]Review Published on 2022-06-012022-09-11 Journal: Innere Medizin (Heidelberg, Germany) [Category] MERS, 변종, 진단, [키워드] activated Adaptability adjuvant adjuvants adverse effects CD4 CD4+ cellular children coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccines COVID-19 vaccines/adverse effects disadvantage Disadvantages English Formulation humoral Humoral immunity Immunity, cellular Immunity, humoral Immunocompromised patients Immunosuppression mRNA vaccines myocarditis Neutralizing antibodies neutralizing antibody pandemic patients physicochemical pregnant women Spectrum Spike protein stability the spike protein thrombotic Thrombotic thrombocytopenia titer vaccination Vaccine vector Viral Viral variants [DOI] 10.1007/s00108-022-01325-9 PMC 바로가기 [Article Type] Review
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccinationCOVID-19 백신 접종 후 노르웨이 의료 종사자의 혈소판 감소증 및 항-PF4/다음이온 항체의 유병률을 확인하기 위한 관찰 연구Observational Study Published on 2021-07-012022-09-11 Journal: Journal of thrombosis and haemostasis : JTH [Category] SARS, 임상, 치료기술, [키워드] activating adverse effects Adverse reactions antibody Antibody testing AstraZeneca AZD1222 clinical trials Cohort Combination COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines COVID-19 vaccines/adverse effects drug related side effects and adverse reactions Effect European country European Medicines Agency first dose Health care Health care worker hospital identify immune Immunity immunoassay individual introduced knowledge majority Norway optical optical density Perceived risk Platelet platelet factor 4 presenting Prevalence recruited referred to Registered reported SARS-CoV-2 screened side Side effect study participant Study participants subject the vaccine thrombocytopenia thrombosis thrombotic Thrombotic thrombocytopenia vaccination Vaccine [DOI] 10.1111/jth.15352 PMC 바로가기 [Article Type] Observational Study